| VERTEX PHARMACEUTICALS INC | 222.10 / -3.83% |
| Date/Time | 09/18 / 17:32 |
| Chg. / Chg.(%) | -8.85 / -3.83% |
| Bid | - |
| Ask | - |
| Open | 227.85 |
| Previous Close | 230.95 |
| High | 231.20 |
| Low | 222.10 |
| Volume [EUR] | 26,331.65 |
| Volume [Units] | 117 |
| Price fixings | 9 |
| ISIN | US92532F1003 |
| Security | VRTX |
| Exchange | Vienna Global Market |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 222.850 |  |
|
| NASDAQ | 265.3900 |  |
2,179,548 |
| Cboe US | 265.57 | |
68,329 |
| IEX | 265.40 | |
35,816 |
| TradeGate | 220.300 | |
470 |
| London Inter.. | 264.05 | |
247 |
| Vienna Globa.. | 222.10 | |
117 |
| gettex | 222.900 | |
70 |
| Frankfurt | 228.2000 |  |
0 |
| München | 226.50 | |
0 |
| Düsseldorf | 218.05 | |
0 |
| Berlin | 226.50 | |
0 |
| Hannover | 226.55 | |
0 |
| Hamburg | 226.55 | |
0 |
| Stuttgart | 226.250 | |
0 |
| Xetra | 230.65 | 185 | |
| Mexico | 5,642.00 | 140 | |
| SIX Swiss Ex.. | 170.61 |
News
- Colorescience® Announces Successful Completion of $30 Million Debt Financing
09/14/2020 / 13:00 - GlobeNewswire - ViralClear to Host Conference Call on September 22, 2020, to Discuss Phase 2 Human Trial of AntiViral Merimepodib Oral Solution for Treatment of COVID-19
09/09/2020 / 18:16 - GlobeNewswire - GBT and Sickle Cell Disease Association of America to Host 9th Annual Sickle Cell Disease (SCD) Therapeutics Conference
09/09/2020 / 14:00 - GlobeNewswire - CRISPR Therapeutics to Present at the Wells Fargo 2020 Virtual Healthcare Conference
09/03/2020 / 14:00 - GlobeNewswire - Spero Therapeutics Announces FDA Acceptance of IND Application for SPR720
08/31/2020 / 14:00 - GlobeNewswire
Real-time